DIGENIC INFLUENCE OF MONOALLELIC PKHD1 LOSS-OF-FUNCTION VARIANTS IN ADULT PATIENTS WITH SPORADIC POLYCYSTIC KIDNEY DISEASE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
DIGENIC INFLUENCE OF MONOALLELIC PKHD1 LOSS-OF-FUNCTION VARIANTS IN ADULT PATIENTS WITH SPORADIC POLYCYSTIC KIDNEY DISEASE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Takuya
Fujimaru
Takuya Fujimaru fujitaku@luke.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan * St. Luke's International Hospital Department of Nephrology Tokyo Japan
Takayasu Mori tmori.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Akinari Sekine akinari-s@toranomon.gr.jp Toranomon Hospital Nephrology Center Tokyo Japan -
Motoko Chiga mchiga.kid@tmd.ac.jp Institute of Science Tokyo Hospital Clinical Laboratory Tokyo Japan -
Shintaro Mandai smandai.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Hiroaki Kikuchi hkikuchi.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Yutaro Mori y-mori.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Fumiaki Ando fandoh.kidc@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Koichiro Susa ksuskid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Soichiro Imori siimori.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Shotaro Naito snaikid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Tatsuya Suwabe suwabe@toranomon.gr.jp Toranomon Hospital Nephrology Center Tokyo Japan -
Yoshifumi Ubara ubara@toranomon.gr.jp Toranomon Hospital Nephrology Center Tokyo Japan -
Shinichi Uchida suchida.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -
Eisei Sohara esohara.kid@tmd.ac.jp Institute of Science Tokyo Department of Nephrology Tokyo Japan -